48:02

Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC

01:04:14

Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers

01:02:43

Modern Team-Based Therapeutic Management for Bladder Cancer Care

41:22

Striking Back at ALL With Antibody Regimens

01:23:25

Harnessing Innovation in Bladder Cancer Care

28:34

“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets

01:24:16

Ten Steps for Highly Successful Myeloma Care

57:45

How Nurses Maximize the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer

01:16:38

Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices

59:06

Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer

01:20:33

Democratizing the CAR-T Experience

01:01:33

Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer

01:03:47

Screening and Early Intervention as the Keys to Success in Lung Cancer

54:55

Prescriptions for Successful Myeloma Care

54:18

Navigating Multidisciplinary Assessment and Treatment Decisions in Early Breast Cancer

52:53

The Convergence of Interventional Radiologists and Oncologists in HCC

01:23:36

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

38:41

From Resistance to Resilience in R/R CLL

01:17:35

Redefining Endometrial and Ovarian Carcinoma Care

59:56

Advancing ADCs in Gynecologic Cancers

53:10

Exploring Newer Time-Limited BTKi Combinations in CLL

53:16

Cracking Down on Post-Transplant CMV

52:28

Updates on CAR-T and BCMA Antibodies in Multiple Myeloma

51:42

Canceling the Cascade of VOD/SOS

58:37

The “Immunosurge” Continues: Expanding the Role of Immunotherapy in NSCLC

50:46

Innovative Options Alongside HCT in AML

53:11

Optimizing the Use of Standard Therapies and Accelerating the Transition of Emerging Options in SCLC

54:35

Peer Pressure: Do You Know Your ADCs? Targeted Delivery of Cytotoxic Payloads in Lung Cancer

52:36

Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations

37:21

Metastatic Melanoma Care: Guidance on Using PD-1/LAG-3 Platforms as Modern First-Line Options

24:25

Exploring New Routes in Immuno-Oncology

36:07

REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE

01:03:59

Selecting and Sequencing of HER2-Targeting Therapies in HER2-Positive Metastatic Breast Cancer

43:21

Leveraging TROP2 Expression in NSCLC

01:29:00

Advancing Personalized Care in RCC

01:24:58

Doing Better Under Pressure in Prostate Cancer

01:30:25

Making an Impact in Bladder Cancer Care

44:19

Synergize for Success in HCC: Immunotherapy Advances and the Role of Interventional Radiology

52:29

Improving Outcomes in Resectable NSCLC: Decisions About Neoadjuvant and Adjuvant Immunotherapy

56:14

Improving Outcomes in Resectable NSCLC With EGFR-Targeted Therapy

49:36

PATHway to Decoding the Impact of Cancer Immunotherapy

01:06:19

The Sequel to the Targeted Therapy Era in CML

01:06:54

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care

48:13

Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer

01:30:16

Empowering Providers and Patients to Battle Advanced Biliary Tract Cancers

01:00:06

An Algorithmic Guide for Clinical Decision-Making in HR+, HER2- EBC and MBC

01:30:40

Calibrating HCC Care: Delivering Effective Tx With Modern Immunotherapy and Targeted Approaches

01:06:57

Sequencing Strategies for Effective Care in R/R CLL

23:53

Equitably Empowering Our Upper GI Cancer Patients Using Plain Language Tools

56:03

Custom Care Compass: Mastering Multifactorial Clinical Decision-Making in HR+, HER2- MBC

41:58

Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLC

01:25:11

Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers

01:01:12

Pioneering Precision Medicine in Bladder Cancer

52:26

Harnessing the Power of the Latest Clinical and Research Advances in SCLC

59:02

Glioblastoma Care: Revolutionary Advances With Innovative Technologies a Modern Systemic Approach

01:54:09

Controlling and Conquering CLL

01:38:22

Achieving Next-Level Care in AML

02:02:50

Achieving Next-Level Care in AML

01:25:24

Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer

23:53

Equitably Empowering Our Upper GI Cancer Patients Using Plain Language Tools